Biomea Fusion, Inc. Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2021-11-03: Form 10-Q; Item Current in its reporting; As filed No.
- 2021-08-11: Form 10-Q; Item Current in its reporting; As filed No.
- 2021-05-27: Form 10-Q; Item Current in its reporting; As filed No.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2021-11-03 | 10-Q | Current in its reporting | No |
| 2021-08-11 | 10-Q | Current in its reporting | No |
| 2021-05-27 | 10-Q | Current in its reporting | No |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |